Heart Retransplantation to Treat a Case of Refractory Cardiac Allograft Vasculopathy / 대한내과학회지
Korean Journal of Medicine
;
: 287-291, 2016.
Article
in English
| WPRIM
| ID: wpr-20331
ABSTRACT
Cardiac allograft vasculopathy is one of the most important causes of poor long-term survival after heart transplantation. The condition tends to be diffuse, usually affecting the mid-to-distal portions of the coronary artery. Reperfusion therapy is ineffective. Everolimus, an inhibitor of proliferation signaling, has been reported to prevent development of the condition; however, the efficacy thereof has not yet been fully accepted. The only definitive treatment for cardiac allograft vasculopathy is retransplantation. Herein, we describe the case of a 15-year-old boy who underwent heart retransplantation because of rapidly progressive cardiac allograft vasculopathy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Reperfusion
/
Heart Transplantation
/
Coronary Vessels
/
Allografts
/
Everolimus
/
Heart
Limits:
Adolescent
/
Humans
/
Male
Language:
English
Journal:
Korean Journal of Medicine
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS